Trtllc · Pressroom

TISSUE REGENERATION TECHNOLOGIES Announces That Shockwave (SoftWaves®) Technology Has Been Utilized to Treat Coronavirus Patients
TRT has filed a Second Patent in the War Against COVID 19. The Patent is For Treatment of Lung Disorders and Diseases such as COVID - 19 with Shockwaves to Treat the Virus & Avert Mortality in Order to Accelerate the Recovery of Afflicted Patients.

April 11, 2020